Healthcare - Biotechnology - NASDAQ - US
$ 3.85
-1.79 %
$ 414 M
Market Cap
-3.35
P/E
INCOME STATEMENT
36.5 M
REVENUE
-114 M
OPERATING INCOME
-102 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Tango Therapeutics, Inc.
| Revenue | 36.5 M |
| Cost Of Revenue | 115 M |
| Gross Profit | -78.7 M |
| Operating Expenses | 151 M |
| Operating Income | -114 M |
| Other Expenses | -12.4 M |
| Net Income | -102 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 36.5 | 24.9 | 37.0 | 7.7 | 24.6 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 115.2 | 4.0 | 2.0 | 1.6 | 32.3 |
| Gross Profit | (78.7) | 20.8 | 35.1 | 6.0 | (7.6) |
| OPERATING INCOME | |||||
| Operating Expenses | 150.7 | 135.9 | 95.2 | 59.9 | 7.2 |
| Selling, General and Administrative Expenses | 35.5 | 30.0 | 17.6 | 9.9 | 7.5 |
| Research and Development Expenses | 115.2 | 105.9 | 77.6 | 50.0 | 32.3 |
| Operating Income | (114.2) | (111.1) | (58.2) | (52.2) | (15.2) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 12.6 | 2.9 | 0.2 | 0.2 | 1.1 |
| Pre-Tax Income | (101.6) | (108.1) | (57.9) | (52.0) | (14.1) |
| NET INCOME | |||||
| Tax Provision | 0.1 | 54 K | 0.3 | (0.1) | 0 |
| Net Income | (101.7) | (108.2) | (58.2) | (51.9) | (14.1) |
| EPS | 1.08 | 1.23 | 0.94 | 1.62 | 1.57 |